Press Releases
Clinical Trials
Medrio and PHASTAR Unite to Offer Data Visualization for Clinical Trials
Medrio, Inc. a leading provider of decentralized and eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets and PHASTAR, a global specialist biometrics clinical research organization (CRO) offering industry-leading data management, data science, statistical consulting, and...
Drug Research
Repligen and Navigo GmbH Announce Launch of Industry First Protein A Ligand for Purification of pH Sensitive Antibodies
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH announced they have completed development and validation of a novel protein A ligand that overcomes challenges associated with the purification of pH sensitive antibodies...
Drug Research
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a broad-based research collaboration with Boehringer Ingelheim International GmbH to use Twist’s proprietary antibody libraries to discover therapeutic...
Packaging & Labelling
CEVA Logistics opens Singapore cold station as part of global healthcare logistics solution
CEVA Logistics opened its temperature-controlled airfreight station today adjacent to Singapore’s Changi International Airport, positioning Singapore as a strategic healthcare logistics hub for the Asia Pacific region.
CEVA’s latest cold station lies within the Free Trade Zone of the Airport...
Drug Research
EnGeneIC develops world-first nanocellular anti-COVID-19 vaccine that defeats mutant viruses and stimulates a broad anti-viral response
EnGeneIC Limited, an Australian, Sydney-based biotechnology company, has developed a globally unique nanocellular technology that in pre-clinical animal studies has been shown to stimulate a broad and powerful anti-COVID-19 immune response and also neutralises the known mutant COVID-19 viruses...
Drug Research
Takeda to Manufacture and Provide 150 Million Doses of Novavax COVID-19 Vaccine Candidate to the Government of Japan
Takeda Pharmaceutical Company Limited announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) will purchase 150 million doses of Novavax’ vaccine candidate (TAK-019 in Japan) manufactured in Japan by Takeda subject to licensing and approval....
Clinical Trials
LTO Network and Sphereon Partner With Triall for World’s First Application of Blockchain Technology to COVID-19 Clinical Trials
Dutch blockchain companies LTO Network and Sphereon have partnered with Triall, experts in the realm of blockchain and clinical research, to deliver the first COVID-19 clinical trials anchored to blockchain technology.
In a critical first step towards advancing the digital...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read